Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01745211
Other study ID # CYN12-PICO-STRIAE_RG4
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2012
Est. completion date November 2013

Study information

Verified date January 2021
Source Cynosure, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm Alexandrite laser.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria 1. Is a healthy male or female between 18 and 85 years old. 2. Has unwanted striae and wishes to undergo laser treatments to remove or improve them. 3. Is willing to consent to participate in the study. 4. Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits. Exclusion Criteria 1. Is hypersensitive to light exposure. 2. Has active localized or systemic infection. 3. Is taking medication(s) for which sunlight is a contraindication. 4. Has a history of squamous cell carcinoma or melanoma. 5. Has a history of keloid scarring. 6. Has used oral isotretinoin (Accutane®) within 12 months of initial treatment or plans on using during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment. 7. Has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications. 8. Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period. 9. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine. 10. Has any other reason determined by the physician to be ineligible to participate in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
755nm Alexandrite Laser
755nm Alexandrite laser with array handpiece

Locations

Country Name City State
United States Laser & Skin Surgery Center of New York New York New York

Sponsors (1)

Lead Sponsor Collaborator
Cynosure, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Photographic Evaluation of Striae Clearance The physician will judge the overall improvement by selecting from improvement ranges of 0-25%, 25-50%, 50-75%, or 75-100% clearance when compared to the baseline. Follow Up Between 1 and 3 Months Post Last Treatment
See also
  Status Clinical Trial Phase
Completed NCT01027793 - Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks Phase 4
Completed NCT01810484 - Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment N/A
Completed NCT01788748 - Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae N/A
Completed NCT01796626 - Clinical Evaluation of M22 ResurFX 1565nm Module N/A